{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:04:52Z","timestamp":1790939092693,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ijpharm.2011.11.025","type":"journal-article","created":{"date-parts":[[2011,11,23]],"date-time":"2011-11-23T00:43:31Z","timestamp":1322009011000},"page":"516-522","source":"Crossref","is-referenced-by-count":34,"title":["Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology"],"prefix":"10.1016","volume":"422","author":[{"given":"Guangpu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianrui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunxian","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lejiao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiang","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2011.11.025_bib0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijpharm.2009.03.029","article-title":"Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors","volume":"375","author":"Ali","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0010","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0015","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1461-5347(99)00177-7","article-title":"Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs","volume":"2","author":"Bohm","year":"1999","journal-title":"Pharm. Sci. Technol. Today"},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejps.2007.06.005","article-title":"A decision-support tool for the formulation of orally active, poorly soluble compounds","volume":"32","author":"Branchu","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0025","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.drudis.2010.02.009","article-title":"Nanonization strategies for poorly water-soluble drugs","volume":"16","author":"Chen","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0030","doi-asserted-by":"crossref","first-page":"375104","DOI":"10.1088\/0957-4484\/19\/37\/375104","article-title":"A facile nanoaggregation strategy for oral delivery of hydrophobic drugs by utilizing acid\u2013base neutralization reactions","volume":"19","author":"Chen","year":"2008","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0378-5173(02)00147-3","article-title":"Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution","volume":"242","author":"Chen","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2008.03.002","article-title":"A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying","volume":"128","author":"de Waard","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijpharm.2010.11.009","article-title":"Preparation of a chemically stable quercetin formulation using nanosuspension technology","volume":"404","author":"Gao","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0050","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1002\/1521-3773(20011203)40:23<4330::AID-ANIE4330>3.0.CO;2-W","article-title":"Organic nanoparticles in the aqueous phase\u2014theory, experiment, and use","volume":"40","author":"Horn","year":"2001","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0055","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2010.10.055","article-title":"Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying","volume":"404","author":"Hu","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejpb.2005.05.009","article-title":"Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation","volume":"62","author":"Keck","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0065","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ejpb.2008.01.007","article-title":"Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process","volume":"69","author":"Kim","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0070","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1248\/cpb.57.657","article-title":"Particle characterization of poorly water-soluble drugs using a spray freeze drying technique","volume":"57","author":"Kondo","year":"2009","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0928-0987(02)00251-8","article-title":"Nanosizing: a formulation approach for poorly-water-soluble compounds","volume":"18","author":"Merisko-Liversidge","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00118-6","article-title":"Nanosuspensions as particulate drug formulations in therapy Rationale for development and what we can expect for the future","volume":"47","author":"Muller","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0085","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1211\/0022357023691","article-title":"Nanosuspensions: a promising drug delivery strategy","volume":"56","author":"Patravale","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/jac\/45.1.77","article-title":"Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection","volume":"45","author":"Peters","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/PDT-120027417","article-title":"Micron-size drug particles: common and novel micronization techniques","volume":"9","author":"Rasenack","year":"2004","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejphar.2008.01.039","article-title":"Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562\/A02 cells","volume":"584","author":"Shi","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0105","doi-asserted-by":"crossref","first-page":"155104","DOI":"10.1088\/0957-4484\/21\/15\/155104","article-title":"In vitroandin vivoevaluation of silybin nanosuspensions for oral and intravenous delivery","volume":"21","author":"Wang","year":"2010","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0110","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbagen.2010.01.001","article-title":"Plagiochin E, an antifungal active macrocyclic bis(bibenzyl), induced apoptosis in Candida albicans through a metacaspase-dependent apoptotic pathway","volume":"1800","author":"Wu","year":"2010","journal-title":"Biochim. Biophys. Acta Gen. Subjects"},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0115","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.bbagen.2009.05.002","article-title":"Plagiochin E, an antifungal bis(bibenzyl), exerts its antifungal activity through mitochondrial dysfunction-induced reactive oxygen species accumulation in Candida albicans","volume":"1790","author":"Wu","year":"2009","journal-title":"Biochim. Biophys. Acta Gen. Subjects"},{"key":"10.1016\/j.ijpharm.2011.11.025_bib0120","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jpba.2008.03.001","article-title":"Liquid chromatography\u2013tandem mass spectrometry assay for the quantitation of plagiochin E and its main metabolite plagiochin E glucuronides in rat plasma","volume":"47","author":"Xing","year":"2008","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311010660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311010660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T08:52:17Z","timestamp":1543395137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517311010660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":24,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0378517311010660"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2011.11.025","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}